Target intelligence / Profile preview

Small nucleolar RNA U105C (RNU105C)

Target
RNU105C
Molecular classification
Small nucleolar RNA (snoRNA), Box C/D snoRNA (defined by conserved box C and D motifs), Non-coding RNA
01

Overview

Small nucleolar RNA U105C is a non-coding RNA molecule of the box C/D class, found primarily in the nucleolus of eukaryotic cells. It forms part of small nucleolar ribonucleoprotein (snoRNP) complexes that direct the site-specific 2’-O-methylation of ribosomal RNA, an essential post-transcriptional modification required for correct ribosome biogenesis[3][5][1]. C/D box snoRNAs, including U105C, are characterized by conserved sequence motifs (boxes C and D) and interact with specific proteins such as fibrillarin to fulfill their function[1][3]. Dysregulation of snoRNAs in general has been associated with various diseases, especially cancer, although there is no direct evidence implicating U105C in specific disease mechanisms or as a drug or biomarker target at this time[5][4]. In summary, U105C is a small nucleolar RNA that participates in ribosomal RNA modification but is not a traditional therapeutic target or biomarker. While snoRNAs collectively have emerging roles in health and disease, information specific to U105C is limited.

Other names
E1-5E1-6U105CRNU105C
02

Mechanism of action

Not applicable — snoRNAs act as guides in ribonucleoprotein complexes to mediate site-directed 2'-O-methylation, not as typical drug targets.

03

Biological functions

2'-O-methylation of ribosomal RNAProcessing and maturation of pre-ribosomal RNA (pre-rRNA)Nucleolar localization and assembly with ribonucleoprotein complexes
04

Disease associations

Other — General snoRNAs, including some box C/D RNAs, have been linked with cancer, cell transformation, or dysregulation in disease, but no specific role is well-established for U105C.Potential biomarker in some transcriptomics studies, but insufficient evidence for U105C specifically.
05

Safety considerations

None identified specifically for this molecule; manipulating core ribosomal RNA processing pathways has theoretical risks, but U105C itself is not targeted clinically.
06

Biomarkers

Other snoRNAs (e.g., SNORD115, SNORD116) serve as cancer, developmental, or neurological disease biomarkers, but U105C is not established as a biomarker.

Beyond the preview

Go deeper on Small nucleolar RNA U105C (RNU105C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA U105C (RNU105C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call